Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Press Release |
HKD | Fiscal Year Ending | | Latest |
(in millions) | Mar-15 | Mar-16 | Mar-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 4 | 97 | 194 | 570 | 894 | 1,272 | 1,066 | 4,193 | 5,529 | 5,581 | | 5,581 |
% Growth | NA | 2454.4% | 99.5% | 194.3% | 57.0% | 42.3% | -16.2% | 293.5% | 31.9% | 0.9% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | (43) | (115) | (170) | (317) | (1,582) | (687) | (1,999) | (3,169) | (2,945) | | (2,945) |
Gross Profit | 4 | 54 | 78 | 400 | 578 | (310) | 379 | 2,194 | 2,360 | 2,636 | | 2,636 |
% Revenue | 100.0% | 55.4% | 40.5% | 70.2% | 64.6% | -24.4% | 35.5% | 52.3% | 42.7% | 47.2% | | 47.2% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2) | (4) | (4) | | (4) |
General and Admin | (61) | (89) | (149) | (367) | (308) | (497) | (406) | (440) | (710) | (651) | | (651) |
Other Inc / (Exp) | 31 | 186 | 373 | (784) | (1,974) | 1,019 | 280 | (196) | 931 | 607 | | 607 |
Total Operating Exp | (30) | 97 | 224 | (1,151) | (2,282) | 522 | (126) | (639) | 217 | (49) | | (49) |
| | | | | | | | | | | | |
Operating Income | (26) | 151 | 302 | (751) | (1,704) | 212 | 253 | 1,556 | 2,577 | 2,587 | | 2,587 |
% Revenue | -687.2% | 155.3% | 156.0% | -131.9% | -190.6% | 16.7% | 23.8% | 37.1% | 46.6% | 46.4% | | 46.4% |
| | | | | | | | | | | | |
Interest Expense | (2) | (39) | (111) | (247) | (223) | (216) | (254) | (1,557) | (1,968) | (1,793) | | (1,793) |
Pre-tax Income | (28) | 112 | 191 | (998) | (1,927) | (3) | (1) | (2) | 609 | 795 | | 795 |
Earnings of Discontinued Ops. | (96) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (5) | (41) | (31) | 76 | (35) | (15) | 12 | 172 | (61) | (102) | | (102) |
Net Income to Company | (129) | 72 | 159 | (922) | (1,962) | (18) | 11 | 170 | 548 | 693 | | 693 |
% Margin | -3390.2% | 73.9% | 82.3% | -161.8% | -219.4% | -1.4% | 1.0% | 4.1% | 9.9% | 12.4% | | 12.4% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | (19) | (11) | (7) | 19 | (339) | (223) | (339) | | (339) |
Net Income to Stockholders | (129) | 72 | 159 | (940) | (1,973) | (26) | 30 | (169) | 325 | 354 | | 354 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 96 | (1) | 0 | 0 | (123) | (259) | (345) | (289) | (309) | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (33) | 70 | 159 | (940) | (2,096) | (285) | (315) | (458) | 15 | 354 | | 354 |
% Margin | -867.3% | 72.7% | 82.3% | -165.1% | -234.4% | -22.4% | -29.5% | -10.9% | 0.3% | 6.3% | | 6.3% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (0.01) | 0.02 | 0.03 | (0.15) | (0.34) | (0.05) | (0.05) | (0.08) | 0.00 | 0.01 | | 0.01 |
Diluted EPS (Continuing Ops) | (0.01) | 0.02 | 0.03 | (0.15) | (0.34) | (0.05) | (0.05) | (0.08) | 0.00 | 0.01 | | 0.01 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 4,235.93 | 4,573.33 | 4,809.18 | 6,128.00 | 6,113.11 | 6,075.67 | 6,022.35 | 6,021.56 | 6,019.43 | 39,280.44 | | 39,280.44 |
WA Diluted Shares Out. | 4,235.93 | 4,596.95 | 4,825.16 | 6,128.00 | 6,113.11 | 6,075.67 | 6,022.35 | 6,021.56 | 6,019.43 | 39,280.44 | | 39,280.44 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (28) | 112 | 191 | (998) | (1,927) | (3) | (1) | (2) | 609 | 795 | | 795 |
Addback: Net Interest Expense | 2 | 39 | 111 | 247 | 223 | 216 | 254 | 1,557 | 1,968 | 1,793 | | 1,793 |
Addback: Other Non Operating Expenses, Total | 0 | 47 | (0) | (2) | 2 | (122) | (20) | 3 | 204 | (283) | | (283) |
Addback: Depreciation & Amortization | 3 | 7 | 15 | 5 | 4 | 4 | 6 | 866 | 1,681 | 1,681 | | 1,681 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 195 | 9 | 74 | 0 | 13 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (34) | (241) | (409) | 590 | 1,963 | (804) | 12 | 1,204 | 781 | (248) | | (248) |
Addback: Gain (Loss) On Sale Of Assets | 1 | 0 | 0 | (15) | 0 | 0 | (171) | (4) | 13 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 23 | 30 | 487 | 27 | (76) | | (76) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | (2) | 21 | 16 | 0 | (190) | (131) | (1,511) | (1,957) | 0 | | 0 |
Adjusted EBITDA | (56) | (35) | (71) | 39 | 274 | (803) | (21) | 2,618 | 3,326 | 3,661 | | 3,661 |
% Margin | -1472.1% | -36.3% | -36.7% | 6.8% | 30.6% | -63.1% | -2.0% | 62.4% | 60.2% | 65.6% | | 65.6% |
| | | | | | | | | | | | |
Adjusted EBIT | (58) | (42) | (86) | 34 | 270 | (807) | (27) | 1,752 | 1,646 | 1,981 | | 1,981 |
% Margin | -1539.3% | -43.2% | -44.6% | 5.9% | 30.2% | -63.4% | -2.5% | 41.8% | 29.8% | 35.5% | | 35.5% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (129) | 72 | 159 | (922) | (1,962) | (18) | 11 | 170 | 548 | 693 | | 693 |
Addback: Unusual Items | (32) | (240) | (388) | 787 | 1,972 | (898) | (261) | 193 | (1,135) | (324) | | (324) |
Less: Tax Benefit of Unusual Items (26%) | 8 | 62 | 101 | (205) | (513) | 233 | 68 | (50) | 295 | 84 | | 84 |
Adjusted Net Income | (153) | (106) | (128) | (339) | (503) | (683) | (182) | 313 | (293) | 453 | | 453 |
% Margin | -4020.8% | -108.9% | -66.0% | -59.6% | -56.2% | -53.6% | -17.1% | 7.5% | -5.3% | 8.1% | | 8.1% |